Rinat Hackmon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rinat Hackmon has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Asaf Ferber
2 shared publicationsMichael Y. Divon
2 shared publicationsBoris Kaplan
1 shared publicationChristopher P. O’rEilly Green
1 shared publicationDahlia Weitzman
1 shared publicationDanielle E. Luciano
Department of Obstetrics & Gynecology, Lenox Hill Hospital, New York, New York USA
1 shared publication
Latest Publications
- 1 April 2007
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (4) , 333.e1-333.e4
Combined analysis with amniotic fluid index and estimated fetal weight for prediction of severe macrosomia at birth
- 1 April 2007
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 196 (4) , 333.e1-333.e4
Combined analysis with amniotic fluid index and estimated fetal weight for prediction of severe macrosomia at birth
- 5 July 2006
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 28 (2) , 204-206
The hazards to practitioners of obstetric and gynecological ultrasound
Objectives To investigate the specific complaints of physicians and technicians performing obstetric and gynecological ultrasound. Methods This was a cross‐sectional retrospective survey. Questionnaires were distributed to members of the Israeli Society of Gynecological Ultrasound, including questions on gender and profession, number and type of scans performed, pain related to profession and any therapy undergone. Statistical analysis included chi‐square or Fisher's exact test, Student's t‐test, Pearson's correlation coefficient and logistic regression. Results Joint pain was reported by 51.7% (30/58) of the technicians compared with 25.3% (19/75) of the physicians (P = 0.002). It was more common in females than in males (P = 0.05) and it was more common among those who performed transabdominal sonography more frequently than they did transvaginal sonography (P = 0.004). There was a significant association between performing transabdominal ultrasound and back pain (P = 0.05). Although females reported pain more frequently, the rate of surgical procedures was higher among males (P < 0.05). Conclusions A technician is 3.5 times more likely to report joint pain than is a physician. Transabdominal sonography is a risk for both joint and back pain. There may be gender differences in pain perception. Copyright © 2006 ISUOG. Published by John Wiley & Sons, Ltd.
- 5 July 2006
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 28 (2) , 204-206
The hazards to practitioners of obstetric and gynecological ultrasound
Objectives To investigate the specific complaints of physicians and technicians performing obstetric and gynecological ultrasound. Methods This was a cross‐sectional retrospective survey. Questionnaires were distributed to members of the Israeli Society of Gynecological Ultrasound, including questions on gender and profession, number and type of scans performed, pain related to profession and any therapy undergone. Statistical analysis included chi‐square or Fisher's exact test, Student's t‐test, Pearson's correlation coefficient and logistic regression. Results Joint pain was reported by 51.7% (30/58) of the technicians compared with 25.3% (19/75) of the physicians (P = 0.002). It was more common in females than in males (P = 0.05) and it was more common among those who performed transabdominal sonography more frequently than they did transvaginal sonography (P = 0.004). There was a significant association between performing transabdominal ultrasound and back pain (P = 0.05). Although females reported pain more frequently, the rate of surgical procedures was higher among males (P < 0.05). Conclusions A technician is 3.5 times more likely to report joint pain than is a physician. Transabdominal sonography is a risk for both joint and back pain. There may be gender differences in pain perception. Copyright © 2006 ISUOG. Published by John Wiley & Sons, Ltd.
- Open Access
- 1 November 2005
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 24 (11) , 1561-1564
Is Notching in the Umbilical Artery Doppler Waveform a Benign Finding?
- 1 November 2005
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 24 (11) , 1561-1564
Open AccessIs Notching in the Umbilical Artery Doppler Waveform a Benign Finding?
- 12 August 2004
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 19 (5) , 404-409
HLA-G Antigen and Parturition: Maternal Serum, Fetal Serum and Amniotic Fluid Levels during Pregnancy
Objective: To determine whether soluble HLA-G1 (sHLA-G1) concentrations in maternal serum and in amniotic fluid are lower at term than in the second trimester. Methods: In this prospective study amniotic fluid and maternal serum samples were aspirated from 21 pregnant women during genetic amniocentesis at 16–20 weeks’ gestation, and from 19 women undergoing a cesarean section at term. In the latter group arterial umbilical cord blood was aspirated as well. sHLA-G1 levels were determined using ELISA assay. This assay included the anti-HLA-G monoclonal antibodies 87G and 16G1, both as capture antibodies and horseradish-peroxidase-labeled rabbit anti-human β2-microglobulin antibodies, as the detection antibody. The relative concentrations of sHLA-G1 were measured from the absorbancy of the blue product at 650 nm. Student’s t test was used for statistical analysis. Results: sHLA-G1 levels in amniotic fluid were significantly lower at term than in the second trimester (0.160 ± 0.05 vs. 0.272 ± 0.150 OD units; p < 0.05). Levels of sHLA-G1 in maternal serum declined toward term, but the difference from the second trimester was not statistically significant (0.266 ± 0.157 vs. 0.205 ± 0.120 OD units; p = 0.193). There was a strong correlation of sHLA-G1 concentrations between cord serum and maternal serum (R2 = 0.79; p < 0.001), but not between cord serum and amniotic fluid (R2 = 0.00004) or amniotic fluid and maternal serum (R2 = 0.02). Conclusions: sHLA-G1 antigen expression is higher in amniotic fluid than in maternal-fetal compartments and significantly decreases toward term. We speculate that the declining amniotic fluid sHLA-G1 levels may stimulate a maternal immunological response against the fetus and contribute to the initiation of parturition.
- 12 August 2004
- Published by S. Karger AG in Fetal Diagnosis and Therapy
- Vol. 19 (5) , 404-409
HLA-G Antigen and Parturition: Maternal Serum, Fetal Serum and Amniotic Fluid Levels during Pregnancy
Objective: To determine whether soluble HLA-G1 (sHLA-G1) concentrations in maternal serum and in amniotic fluid are lower at term than in the second trimester. Methods: In this prospective study amniotic fluid and maternal serum samples were aspirated from 21 pregnant women during genetic amniocentesis at 16–20 weeks’ gestation, and from 19 women undergoing a cesarean section at term. In the latter group arterial umbilical cord blood was aspirated as well. sHLA-G1 levels were determined using ELISA assay. This assay included the anti-HLA-G monoclonal antibodies 87G and 16G1, both as capture antibodies and horseradish-peroxidase-labeled rabbit anti-human β2-microglobulin antibodies, as the detection antibody. The relative concentrations of sHLA-G1 were measured from the absorbancy of the blue product at 650 nm. Student’s t test was used for statistical analysis. Results: sHLA-G1 levels in amniotic fluid were significantly lower at term than in the second trimester (0.160 ± 0.05 vs. 0.272 ± 0.150 OD units; p < 0.05). Levels of sHLA-G1 in maternal serum declined toward term, but the difference from the second trimester was not statistically significant (0.266 ± 0.157 vs. 0.205 ± 0.120 OD units; p = 0.193). There was a strong correlation of sHLA-G1 concentrations between cord serum and maternal serum (R2 = 0.79; p < 0.001), but not between cord serum and amniotic fluid (R2 = 0.00004) or amniotic fluid and maternal serum (R2 = 0.02). Conclusions: sHLA-G1 antigen expression is higher in amniotic fluid than in maternal-fetal compartments and significantly decreases toward term. We speculate that the declining amniotic fluid sHLA-G1 levels may stimulate a maternal immunological response against the fetus and contribute to the initiation of parturition.